Patologian yksikkö

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Aaltonen M et al. Meconium aspiration induces neuronal injury in piglets.
2 Aho H. Labqualityn histopatologian kierroksen palaute: Endometriumin adenokarsinooma.
3 Aho H et al. Patologian laatutunnus on toimintayksikön sertifiointia. Uuden järjestelmän mukainen toiminta.
4 Anttonen A-K et al. The gene disrupted in Marinesco-Sjögren syndrome encodes SIL1, an HSPA5 cochaperone.
5 Bendardaf R et al. E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer.
6 Buhmeida A et al. DNA image cytometry in prognostication of colorectal cancer: Practical considerations of the technique and interpretation of the histograms.
7 Buhmeida A et al. Nuclear area is a prognostic determinant in advanced colorectal cancer.
8 Carpén O. Sarcomeric Proteins in LGMD.
9 Collan Y et al. Value of electron microscopy in kidney biopsy diagnosis.
10 Eklund T et al. On visual exploration of breast cancer data using the self-organizing map.
11 Gontier Y et al. The Z-disc proteins myotilin and FATZ-1 interact with each other and are connected to the sarcolemma via muscle-specific filamins.
12 Grönholm M et al. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
13 Grönroos J et al. Roles of group IIA phospholipase A2 and complement in killing of bacteria by acute phase serum.
14 Grönroos JO. Secreted Phospholipases A2 in Host Defense against Bacteria.
15 Heiska L, Carpén O. Src phosphorylates ezrin at tyrosine 477 and induces a phosphospecific association between ezrin and a kelch-repeat protein family member.
16 Hilska M et al. The significance of tumor markers for proliferation and apoptosis in predicting survival in colorectal cancer.
17 Immonen-Räihä P et al. Mammographic screening reduces risk of breast carcinoma recurrence.
18 Jalava P et al. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
19 Jalava-Karvinen P. Biological Prognostic Factors in Breast Cancer. Immunohistochemical Analysis of Cystatin , Bcl-2, ErbB2, ER, PgR, and Ki-67 in Infiltrating Breast Carcinomas .
20 Järvinen TAH et al. Muscle injuries: biology and treatment.
21 Kalimo H, ed. Cerebrovascular Diseases.
22 Kalimo H, Kalaria R. Hereditary Forms of Vascular Dementia.
23 Kari O et al. Group IIA phospholipase A2 concentration of tears in patients with ocular rosacea.
24 Kivinen K et al. Caspase-3 is required in the apoptotic disintegration of the nuclear matrix.
25 Korja M et al. Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas.
26 Koskivuo I et al. Sentinel node metastasectomy in thin =/<1-mm melanoma.
27 Kveiborg M et al. A role for ADAM12 in breast tumor progression and stromal cell apoptosis.
28 Lukkarinen HP et al. Angiotensin II receptor inhibition prevents pneumocyte apoptosis in surfactant-depleted rat lungs.
29 Lundkvist J et al. Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype.
30 Luukkaa H et al. Salivary gland cancer in Finland 1991-96: An evaluation of 237 cases.
31 Mologni L et al. Characterization of mouse myotilin and its promoter.
32 Nandelstadh P von et al. Actin-organising properties of the muscular dystrophy protein myotilin.
33 Nevalainen TJ et al. Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum.
34 Otey CA et al. The palladin/myotilin/myopalladin family of actin-associated scaffolds.
35 Roine S et al. Neurologic symptoms are common during gestation and puerperium in CADASIL.
36 Roine S. Clinical and Imaging Findings in CADASIL.
37 Ruohonen S et al. Cytokine responses during chronic denervation.
38 Rönty M et al. Involvement of palladin and alpha-actinin in targeting of the Abl/Arg kinase adaptor ArgBP2 to the actin cytoskeleton.
39 Salminen E et al. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer.
40 Toivonen T et al. Cytopathology in Finland.
41 Vähäsilta T et al. Cardiomyocyte apoptosis after antegrade and retrograde cardioplegia.

Julkaisutietokanta 4.10.2006 Publications Data Base 4.10.2006